Bacil Pharma Limited announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced total revenue was INR 183,000 compared to INR 471,000 a year ago. Net loss was INR 224,000 compared to INR 521,000 a year ago. Basic loss per share was INR 0.04 compared to INR 0.09 a year ago. For the full year, total revenue was INR 1.428 million compared to INR 941,000 a year ago. Net loss was INR 3.152 million compared to INR 3.424 million a year ago. Basic loss per share was INR 0.54 compared to INR 0.58 a year ago.